Why Emergent Biosolutions Inc (EBS) Stock Is Rising
As of 2026-08-27, Emergent Biosolutions Inc (EBS) has a next-year EPS growth estimate of 190.99%. Featured in our EPS revision report on 2026-08-27.
Why EBS Stock Is Rising
- ·Current-Year Growth: Projected at -76.50%, supporting the forward estimate revision.
News Context
The primary structural driver is a sharp upward revision to next-year EPS growth estimates, now flagged at 190.99%. This upgrade follows Emergent BioSolutions’ Q1 2026 results, which reported strong revenue and an earnings beat. That quarterly outperformance appears to have triggered the estimate increase, and the elevated growth forecast has sustained the stock's positive momentum.
Generated 2026-08-27 · news as of 2026-08-27
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 190.99%
- EPS growth this year
- -76.50%
- EPS next quarter (est)
- -$0.39
- Last price
- $5.97
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-27 | 190.99% | -76.50% | -$0.39 | $5.97 |
| 2026-08-26 | 190.99% | -76.50% | -$0.39 | $5.97 |
| 2026-08-25 | 190.99% | -76.50% | -$0.39 | $5.64 |
| 2026-08-24 | 190.99% | -76.50% | -$0.39 | $5.18 |
| 2026-08-23 | 190.99% | -76.50% | -$0.39 | $5.08 |
| 2026-08-21 | 190.99% | -76.50% | -$0.39 | $5.08 |
| 2026-08-09 | 2933.33% | -98.04% | -$0.24 | $4.84 |
| 2026-08-07 | 2933.33% | -98.04% | -$0.24 | $4.84 |
| 2026-08-06 | 2933.33% | -98.04% | -$0.24 | $5.31 |
| 2026-08-05 | 180.00% | -78.76% | -$0.09 | $7.54 |
| 2026-08-04 | 180.00% | -78.76% | -$0.09 | $7.57 |
| 2026-08-03 | 180.00% | -78.76% | -$0.09 | $7.41 |
| 2026-08-02 | 180.00% | -78.76% | -$0.09 | $7.22 |
| 2026-07-31 | 180.00% | -78.76% | -$0.09 | $7.22 |
| 2026-07-30 | 180.00% | -78.76% | -$0.09 | $7.26 |
| 2026-07-29 | 180.00% | -78.76% | -$0.09 | $7.35 |
| 2026-07-28 | 180.00% | -78.76% | -$0.09 | $7.31 |
| 2026-07-27 | 180.00% | -78.76% | -$0.09 | $7.33 |
| 2026-07-26 | 180.00% | -78.76% | -$0.09 | $7.26 |
| 2026-07-24 | 180.00% | -78.76% | -$0.09 | $7.26 |
| 2026-07-23 | 180.00% | -78.76% | -$0.09 | $7.50 |
| 2026-07-22 | 180.00% | -78.76% | -$0.09 | $7.58 |
| 2026-07-21 | 180.00% | -78.76% | -$0.09 | $7.65 |
| 2026-07-20 | 180.00% | -78.76% | -$0.09 | $7.69 |
| 2026-07-19 | 180.00% | -78.76% | -$0.09 | $7.63 |
| 2026-07-17 | 180.00% | -78.76% | -$0.09 | $7.63 |
| 2026-07-16 | 180.00% | -78.76% | -$0.09 | $7.69 |
| 2026-07-15 | 180.00% | -78.76% | -$0.09 | $7.89 |
| 2026-07-14 | 180.00% | -78.76% | -$0.09 | $7.50 |
| 2026-07-13 | 180.00% | -78.76% | -$0.09 | $8.01 |
Reports Featuring EBS
Recent News
- Emergent BioSolutions Inc. Q1 2026 Earnings Call SummaryMoby
- Emergent BioSolutions Inc (EBS) Q1 2026 Earnings Call Highlights: Strong Revenue and Strategic ...GuruFocus.com
- Emergent Biosolutions: Q1 Earnings SnapshotAssociated Press
- Emergent BioSolutions Reports First Quarter 2026 Financial ResultsGlobeNewswire
Screen Performance
Aggregate stats across all 2015 tickers our top-EPS-revision screen has flagged over the past 148 days.
- Median return since detection
- +2.8%
- % of tickers in the green
- 56%
- Median return on winners
- +20.1%
- Large revisions captured
- 1614
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Emergent Biosolutions Inc (EBS) stock go up recently?▾
Emergent Biosolutions Inc (EBS) stock has risen following an analyst upgrade of its next-year EPS growth estimate on 2026-08-21. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Emergent Biosolutions Inc's next-year EPS growth estimate?▾
As of 2026-08-27, Emergent Biosolutions Inc (EBS) has a next-year EPS growth estimate of 190.99%, based on analyst consensus.
When was the latest EPS estimate revision for EBS?▾
The most recent revision occurred on 2026-08-21, when analysts adjusted the next-year EPS growth estimate from 2933.33% to 190.99%.
What sector and industry does Emergent Biosolutions Inc belong to?▾
Emergent Biosolutions Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. EBS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Emergent Biosolutions Inc (EBS) appears here because it was detected by our daily top-EPS-revision-performer screen.